ビーリンサイトの世界市場レポート 2025年：疫学、パイプライン分析、市場インサイトと予測

ビーリンサイト市場規模は、今後数年で力強い成長が見込まれます。2029年にはCAGR6％で10億2,210万米ドルに成長します。予測期間の成長は、患者中心のケアモデルへのシフトの増加、注射療法の利用可能性の増加、製薬会社の関心の高まり、QOL向上への注目の高まり、成人のALL発症率の上昇などに起因すると考えられます。予測期間における主要動向としては、技術進歩のための研究資金、二重特異性t細胞エンゲージャーの出現、細胞療法の進歩、患者モニタリング技術の強化、製剤化技術の向上などが挙げられます。

白血病の罹患率の増加は、ビーリンサイト市場の拡大を促進すると予想されます。白血病は、骨髄などの造血組織に発生するがんの一種であり、異常な白血球の過剰産生を引き起こし、正常な血球機能を破壊します。白血病患者の増加は、高齢化、環境暴露、遺伝的素因、診断能力の向上などの要因に関連しています。ビーリンサイトは、二重特異性T細胞エンゲイジャーとして白血病治療に重要な役割を果たし、特に急性リンパ芽球性白血病（ALL）患者において、免疫系が白血病細胞を標的として排除するのを助ける。例えば、2024年1月、米国がん協会は、2024年に新たに発生する白血病患者数を約6万2,770人と予測しており、2023年の5万9,610人から増加しています。その結果、白血病罹患率の上昇がビーリンサイト市場の成長に拍車をかけています。

ヘルスケア支出の増加は、ビーリンサイト市場の成長をサポートすると予想されます。ヘルスケア支出には、パーソナルケア、公衆衛生プログラム、健康管理など、ヘルスケアサービスや商品に対するすべての支出が含まれます。この支出は、人口増加、人口動態の高齢化、サービスコストの上昇、慢性疾患の罹患率の上昇、医療技術の進歩などの要因により増加しています。ヘルスケア支出の増加は、ビーリンサイトのような先進的がん治療へのアクセスを改善し、より広範な導入と患者の転帰改善を促進します。例えば、2024年5月に英国国家統計局が発表した報告書によると、2023年の英国のヘルスケア支出は約3,630億米ドルに達し、前年比5.6％増となり、2022年の0.9％増を大きく上回りました。その結果、ヘルスケア支出の増加がビーリンサイト市場を牽引しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 バイオ医薬品市場における製品特性

• 分子タイプ
• 投与経路（ROA）
• 作用機序（MOA）
• 安全性と有効性

第4章 市場動向と戦略

第5章 市場-マクロ経済シナリオ金利、インフレ、地政学、新型コロナウイルス感染症、景気回復が市場に与える影響を含むマクロ経済シナリオ

第6章 世界の成長分析と戦略分析フレームワーク

• 世界のビーリンサイト：PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のビーリンサイト市場：成長率分析
• 世界のビーリンサイト市場の実績：規模と成長、2019～2024年
• 世界のビーリンサイト市場の予測：規模と成長、2024～2029年、2034年
• 世界のビーリンサイト：総潜在市場規模（TAM）

第7章 世界市場の価格分析と予測

第8章 市場セグメンテーション

• 世界のビーリンサイト市場：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• プレフィルド
• 非プレフィルド
• 世界のビーリンサイト市場：流通チャネル別、実績と予測、2019～2024年、2024～2029年、2034年
• 病院薬局
• 小売薬局
• オンライン薬局
• 世界のビーリンサイト市場：用途別、実績と予測、2019～2024年、2024～2029年、2034年
• 急性リンパ性白血病
• その他の血液疾患
• 世界のビーリンサイト市場：エンドユーザー別、実績と予測、2019～2024年、2024～2029年、2034年
• 病院
• クリニック
• 研究機関

第9章 臨床適応症の世界市場疫学

• 薬剤の副作用
• 臨床適応症の発症率と有病率

第10章 地域別・国別分析

• 世界のビーリンサイト市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界のビーリンサイト市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第11章 アジア太平洋市場

第12章 中国市場

第13章 インド市場

第14章 日本市場

第15章 オーストラリア市場

第16章 韓国市場

第17章 西欧市場

第18章 英国市場

第19章 ドイツ市場

第20章 フランス市場

第21章 東欧市場

第22章 北米市場

第23章 米国市場

第24章 カナダ市場

第25章 南米市場

第26章 中東市場

第27章 アフリカ市場

第28章 競合情勢と企業プロファイル

• ビーリンサイト市場：競合情勢
• ビーリンサイト市場：企業プロファイル
  • Amgen Inc.

第29章 世界市場：パイプライン分析

第30章 世界の市場競合ベンチマーキングとダッシュボード

第31章 主要な合併と買収

第32章 最近の市場動向

第33章 市場の潜在力が高い国、戦略

• ビーリンサイト市場、2029年：新たな機会を提供する国
• ビーリンサイト市場、2029年：新たな機会を提供するセグメント
• ビーリンサイト市場、2029年：成長戦略
  • 市場動向による戦略
  • 競合の戦略

第34章 付録

Blincyto (blinatumomab) is a prescription medication designed for the treatment of specific blood cancers. As a bi-specific T-cell engager (BiTE) antibody construct, it operates by linking cancerous B-cells with T-cells (a type of immune cell), harnessing the immune system to identify and eliminate the cancerous B-cells.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The primary types of blincyto are prefilled and non-prefilled formulations. The prefilled option comes in ready-to-use syringes or vials, simplifying preparation and administration. It is distributed through hospital pharmacies, retail pharmacies, and online pharmacies, and is used to treat acute lymphoblastic leukemia and other hematological disorders. Key users include hospitals, clinics, and research institutions.

The blincyto market research report is one of a series of new reports from The Business Research Company that provides blincyto market statistics, including blincyto industry global market size, regional shares, competitors with a blincyto market share, detailed blincyto market segments, market trends and opportunities, and any further data you may need to thrive in the blincyto industry. This blincyto market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The blincyto market size is expected to see strong growth in the next few years. It will grow to $1,022.1 million in 2029 at a compound annual growth rate (CAGR) of 6%. The growth in the forecast period can be attributed to increasing shift towards patient-centric care models, increasing availability of injectable therapies, increasing interest from pharmaceutical companies, increasing focus on quality of life improvements, rising incidence of ALL in adults. Major trends in the forecast period include research funding for technological advancements, emergence of bispecific t-cell engagers, advancements in cell therapy, enhanced patient monitoring technologies, improved formulation techniques.

The growing incidence of leukemia is anticipated to drive the expansion of the Blincyto market. Leukemia, a type of cancer originating in blood-forming tissues like bone marrow, causes the overproduction of abnormal white blood cells, which disrupt normal blood cell function. The rise in leukemia cases is linked to factors such as an aging population, environmental exposures, genetic predispositions, and improved diagnostic capabilities. Blincyto plays a critical role in treating leukemia as a bispecific T-cell engager, helping the immune system target and eliminate leukemia cells, especially in patients with acute lymphoblastic leukemia (ALL). For example, in January 2024, the American Cancer Society projected approximately 62,770 new leukemia cases in the United States in 2024, an increase from 59,610 in 2023. As a result, the rising incidence of leukemia is fueling the growth of the Blincyto market.

An increase in healthcare spending is expected to support the growth of the Blincyto market. Healthcare spending encompasses all expenditures on health services and goods, including personal care, public health programs, and health administration. This spending is rising due to factors such as population growth, aging demographics, rising service costs, higher chronic illness prevalence, and advancements in medical technology. The rise in healthcare spending improves access to advanced cancer treatments like Blincyto, facilitating wider adoption and better patient outcomes. For instance, in May 2024, a report from the Office for National Statistics in the UK revealed that healthcare expenditure in the UK reached around $363 billion in 2023, representing a 5.6% increase from the previous year, well above the 0.9% increase in 2022. Consequently, higher healthcare spending is driving the Blincyto market.

A key trend in the Blincyto market is the focus on developing innovative therapies, including immuno-oncology treatments, to target and destroy cancer cells. Immuno-oncology therapies use the body's immune system to recognize and eliminate cancer cells. For example, in June 2024, Amgen Inc., a U.S.-based biotechnology company, received FDA approval for Blincyto (blinatumomab) to treat CD19-positive Philadelphia chromosome-negative B-cell precursor acute lymphoblastic leukemia (B-ALL) in both adult and pediatric patients, regardless of the presence of measurable residual disease (MRD). Blincyto is a bispecific T-cell engager (BiTE) that binds to CD19 on B-cell tumors and CD3 on T-cells, guiding T-cells to target and destroy cancer cells.

Key player operating in the blincyto market is Amgen Inc.

North America was the largest region in the Blincyto market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in blincyto report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the blincyto market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The blincyto market consists of sales of oncology medications, biosimilars, immunotherapy drugs, anti-inflammatory medications and hematology medications. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Blincyto Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on blincyto market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 10 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-4 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for blincyto ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The blincyto market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Prefilled; Non-Prefilled
• 2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
• 3) By Application: Acute Lymphoblastic Leukemia; Other Hematological Disorders
• 4) By End-User: Hospitals; Clinics; Research Institutions
• Companies Mentioned: Amgen Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Blincyto Market Characteristics

3. Blincyto Market Biologic Drug Characteristics

• 3.1. Molecule Type
• 3.2. Route Of Administration (ROA)
• 3.3. Mechanism Of Action (MOA)
• 3.4. Safety And Efficacy

4. Blincyto Market Trends And Strategies

5. Blincyto Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

6. Global Blincyto Growth Analysis And Strategic Analysis Framework

• 6.1. Global Blincyto PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 6.2. Analysis Of End Use Industries
• 6.3. Global Blincyto Market Growth Rate Analysis
• 6.4. Global Blincyto Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 6.5. Global Blincyto Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 6.6. Global Blincyto Total Addressable Market (TAM)

7. Global Blincyto Market Pricing Analysis & Forecasts

8. Blincyto Market Segmentation

• 8.1. Global Blincyto Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Prefilled
• Non-Prefilled
• 8.2. Global Blincyto Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• 8.3. Global Blincyto Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Acute Lymphoblastic Leukemia
• Other Hematological Disorders
• 8.4. Global Blincyto Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Clinics
• Research Institutions

9. Global Blincyto Market Epidemiology Of Clinical Indications

• 9.1. Drug Side Effects
• 9.2. Incidence And Prevalence of Clinical Indications

10. Blincyto Market Regional And Country Analysis

• 10.1. Global Blincyto Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. Global Blincyto Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Asia-Pacific Blincyto Market

• 11.1. Asia-Pacific Blincyto Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Blincyto Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Asia-Pacific Blincyto Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Asia-Pacific Blincyto Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. China Blincyto Market

• 12.1. China Blincyto Market Overview
• 12.2. China Blincyto Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 12.3. China Blincyto Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 12.4. China Blincyto Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

13. India Blincyto Market

• 13.1. India Blincyto Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. India Blincyto Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. India Blincyto Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. Japan Blincyto Market

• 14.1. Japan Blincyto Market Overview
• 14.2. Japan Blincyto Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. Japan Blincyto Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. Japan Blincyto Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Australia Blincyto Market

• 15.1. Australia Blincyto Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.2. Australia Blincyto Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Australia Blincyto Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. South Korea Blincyto Market

• 16.1. South Korea Blincyto Market Overview
• 16.2. South Korea Blincyto Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. South Korea Blincyto Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.4. South Korea Blincyto Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Western Europe Blincyto Market

• 17.1. Western Europe Blincyto Market Overview
• 17.2. Western Europe Blincyto Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Western Europe Blincyto Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.4. Western Europe Blincyto Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. UK Blincyto Market

• 18.1. UK Blincyto Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. UK Blincyto Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. UK Blincyto Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Germany Blincyto Market

• 19.1. Germany Blincyto Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Germany Blincyto Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Germany Blincyto Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. France Blincyto Market

• 20.1. France Blincyto Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. France Blincyto Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. France Blincyto Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Blincyto Market

• 21.1. Eastern Europe Blincyto Market Overview
• 21.2. Eastern Europe Blincyto Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Blincyto Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Blincyto Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. North America Blincyto Market

• 22.1. North America Blincyto Market Overview
• 22.2. North America Blincyto Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. North America Blincyto Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.4. North America Blincyto Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. USA Blincyto Market

• 23.1. USA Blincyto Market Overview
• 23.2. USA Blincyto Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. USA Blincyto Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. USA Blincyto Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. Canada Blincyto Market

• 24.1. Canada Blincyto Market Overview
• 24.2. Canada Blincyto Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. Canada Blincyto Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. Canada Blincyto Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. South America Blincyto Market

• 25.1. South America Blincyto Market Overview
• 25.2. South America Blincyto Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. South America Blincyto Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. South America Blincyto Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. Middle East Blincyto Market

• 26.1. Middle East Blincyto Market Overview
• 26.2. Middle East Blincyto Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. Middle East Blincyto Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. Middle East Blincyto Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Africa Blincyto Market

• 27.1. Africa Blincyto Market Overview
• 27.2. Africa Blincyto Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Africa Blincyto Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.4. Africa Blincyto Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Blincyto Market Competitive Landscape And Company Profiles

• 28.1. Blincyto Market Competitive Landscape
• 28.2. Blincyto Market Company Profiles
  • 28.2.1. Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis

29. Global Blincyto Market Pipeline Analysis

• 29.1. High Level Clinic Trail Information

30. Global Blincyto Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Blincyto Market

32. Recent Developments In The Blincyto Market

33. Blincyto Market High Potential Countries, Segments and Strategies

• 33.1 Blincyto Market In 2029 - Countries Offering Most New Opportunities
• 33.2 Blincyto Market In 2029 - Segments Offering Most New Opportunities
• 33.3 Blincyto Market In 2029 - Growth Strategies
  • 33.3.1 Market Trend Based Strategies
  • 33.3.2 Competitor Strategies

34. Appendix

• 34.1. Abbreviations
• 34.2. Currencies
• 34.3. Historic And Forecast Inflation Rates
• 34.4. Research Inquiries
• 34.5. The Business Research Company
• 34.6. Copyright And Disclaimer